Skip to main content
All lobbying filings

LEWIS-BURKE ASSOCIATES, LLC

Lobbying for FERMIFORWARD DISCOVERY GROUP, LLC

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $40,000.00 income · posted Jul 17, 2026

Official filing document

 Bills named in this filing 9
  • HR 9022
    Energy and Water Development and Related Agencies Appropriations Act, 2027
  • HR 9495
    Department of Defense Appropriations Act, 2027
  • S 579
    Department of Energy Quantum Leadership Act of 2025
  • HR 8462
    National Quantum Initiative Reauthorization Act
  • S 3597
    National Quantum Initiative Reauthorization Act of 2026
  • HR 4496
    Restore and Modernize Our National Laboratories Act of 2025
  • S 2325
    Restore and Modernize Our National Laboratories Act of 2025
  • HR 4490
    PARTNER Act
  • S 1579
    PARTNER with ASEAN, CERN, and PIF Act
 Lobbying activity 2
Budget/Appropriations

H.R. 9022, FY 2027 Energy and Water Development Appropriations, Issues pertaining to DOE Office of Science, High Energy Physics, lab infrastructure, and emerging technologies. H.R. 9495, FY 2027 Defense Appropriations, Issues pertaining to accelerators for defense applications. Issues pertaining to research infrastructure and DOE AI initiative.

Science/Technology

S. 579, DOE Quantum Leadership Act, Issues pertaining to DOE quantum research, infrastructure, and workforce development. H.R. 8462, S.3597, The National Quantum Initiative Reauthorization, Issues pertaining to DOE quantum research, infrastructure, and workforce development. H.R. 4496, S. 2325, Restore and Modernize Our National Laboratories Act, Issues pertaining to DOE national lab infrastructure. H.R. 4490, S. 1579, Providing Appropriate Recognition and Treatment Needed to Enhance Relations Act, Issues pertaining to CERN privileges. Issues pertaining to DOE artificial intelligence research and workforce development programs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem